International Association for the Study of Lung Cancer (IASLC) shared a post on X:
“How is EGFR-mutant NSCLC managed in Romania? In this episode of Lung Cancer Considered in Romanian, Mihaela Aldea speaks with Dr. Miruna Grecea and Dr. Andrei Ungureanu about diagnosis, multidisciplinary care and post-CRT consolidation with osimertinib.”
More posts featuring International Association for the Study of Lung Cancer.